Anthony An‐Fa Dahm Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anthony An‐Fa Dahm Chen has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Jiannan Li
Department of Orthopaedic Surgery Stanford University Stanford California USA
3 shared publicationsDavid G. Mohler
Department of Orthopaedic Surgery Stanford University Stanford California USA
2 shared publicationsElaine Lui
Department of Orthopaedic Surgery, School of Medicine, Stanford University, Stanford, California 94304, USA
2 shared publicationsMichael J. Gardner
Department of Orthopaedic Surgery Stanford University Stanford California USA
2 shared publications- Yunzhi Peter Yang
Department of Orthopaedic Surgery Stanford University Stanford California USA
2 shared publications Aaron James
Department of Pathology, School of Medicine, Johns Hopkins University, Maryland 21218, USA
1 shared publication
Latest Publications
- 30 October 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (11) , e70179
Tunable Polycaprolactone‐Gelatin Methacryloyl Composites for Fused Deposition Modeling Musculoskeletal Scaffold Fabrication
The global musculoskeletal burden continues to outpace standard of care transplantation efforts and existing tissue engineering solutions, necessitating further development of scalable biomaterials. In this study, we introduce a novel synthesis of polycaprolactone‐gelatin methacryloyl (PCL‐GelMA) composite filament, compatible with standard fused deposition modeling (FDM) 3D printers, for scalable and customizable scaffold fabrication. By incorporating 15% and 30% (w/w) GelMA into a PCL matrix, we achieved tunable modulation of surface roughness, hydrophilicity, and degradation kinetics. Mechanical testing revealed nonlinear dependencies between GelMA content and tensile properties, suggesting that variation in GelMA particle size and distribution leads to a concentration‐dependent trade‐off between stiffness and structural integrity. Human mesenchymal stem cells (hMSCs) cultured on printed scaffolds maintained viability and proliferative capacity. By mitigating solvent toxicity through upstream processing, physically integrating constituents into a unified bulk matrix, and leveraging the accessibility of FDM printing, this material platform enables scalable translation and further biomaterial exploration.
- 30 October 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (11) , e70179
Tunable Polycaprolactone‐Gelatin Methacryloyl Composites for Fused Deposition Modeling Musculoskeletal Scaffold Fabrication
The global musculoskeletal burden continues to outpace standard of care transplantation efforts and existing tissue engineering solutions, necessitating further development of scalable biomaterials. In this study, we introduce a novel synthesis of polycaprolactone‐gelatin methacryloyl (PCL‐GelMA) composite filament, compatible with standard fused deposition modeling (FDM) 3D printers, for scalable and customizable scaffold fabrication. By incorporating 15% and 30% (w/w) GelMA into a PCL matrix, we achieved tunable modulation of surface roughness, hydrophilicity, and degradation kinetics. Mechanical testing revealed nonlinear dependencies between GelMA content and tensile properties, suggesting that variation in GelMA particle size and distribution leads to a concentration‐dependent trade‐off between stiffness and structural integrity. Human mesenchymal stem cells (hMSCs) cultured on printed scaffolds maintained viability and proliferative capacity. By mitigating solvent toxicity through upstream processing, physically integrating constituents into a unified bulk matrix, and leveraging the accessibility of FDM printing, this material platform enables scalable translation and further biomaterial exploration.
- 29 July 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 222, 636-650
A bioactive intramedullary implant enables accelerated bone regeneration and early load-bearing in distraction osteogenesis
- 29 July 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 222, 636-650
A bioactive intramedullary implant enables accelerated bone regeneration and early load-bearing in distraction osteogenesis
- 18 February 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (3) , e70051
3D Printing Polycaprolactone‐Gelatin for Musculoskeletal Tissue Engineering
In musculoskeletal tissue engineering, there is a need for bone implants that are biocompatible, resorbable, promote tissue regeneration, and degrade at a rate matching healing. Polycaprolactone (PCL), an FDA‐approved biodegradable and bioinert polymer, can be functionalized with natural components without harsh crosslinking. This study presents the first demonstration of a homogeneous bulk polycaprolactone‐gelatin (PCL‐gelatin, PG) composite containing self‐assembled gelatin nanoparticles that retain bioactivity despite thermal processing for 3D printing applications. PG composites with varying gelatin content (10%, 20%, and 30%) and β‐tricalcium phosphate incorporation were fabricated through casting and melt processing into printable filaments at 110°C. Comprehensive characterization using mechanical testing, contact angle measurements, FTIR, TGA, EDS, and SEM confirmed homogeneous gelatin distribution as nanoscale particles throughout the PCL matrix, with systematic increases in hydrophilicity and enhanced mechanical properties proportional to gelatin content. Accelerated degradation studies revealed tunable degradation rates correlated with gelatin concentration, while in vitro studies with human mesenchymal stem cells demonstrated enhanced proliferation and early osteogenic differentiation markers, particularly in PG30 compositions. Subcutaneous implantation in rats over 24 weeks showed biocompatibility comparable to PCL with minimal inflammatory response and biphasic degradation behavior characterized by initial swelling followed by controlled volume reduction. In critical‐size femoral defects, PG30 exhibited superior early mechanical properties and increased preosteoblast density at bone interfaces compared to PCL and PCL‐TCP controls at 4 weeks. This developed fabrication methodology enables precise spatial control through 3D printing while preserving gelatin bioactivity. This approach offers a promising advancement for tissue engineering applications requiring enhanced cellular interactions and controlled degradation.
- 18 February 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (3) , e70051
3D Printing Polycaprolactone‐Gelatin for Musculoskeletal Tissue Engineering
In musculoskeletal tissue engineering, there is a need for bone implants that are biocompatible, resorbable, promote tissue regeneration, and degrade at a rate matching healing. Polycaprolactone (PCL), an FDA‐approved biodegradable and bioinert polymer, can be functionalized with natural components without harsh crosslinking. This study presents the first demonstration of a homogeneous bulk polycaprolactone‐gelatin (PCL‐gelatin, PG) composite containing self‐assembled gelatin nanoparticles that retain bioactivity despite thermal processing for 3D printing applications. PG composites with varying gelatin content (10%, 20%, and 30%) and β‐tricalcium phosphate incorporation were fabricated through casting and melt processing into printable filaments at 110°C. Comprehensive characterization using mechanical testing, contact angle measurements, FTIR, TGA, EDS, and SEM confirmed homogeneous gelatin distribution as nanoscale particles throughout the PCL matrix, with systematic increases in hydrophilicity and enhanced mechanical properties proportional to gelatin content. Accelerated degradation studies revealed tunable degradation rates correlated with gelatin concentration, while in vitro studies with human mesenchymal stem cells demonstrated enhanced proliferation and early osteogenic differentiation markers, particularly in PG30 compositions. Subcutaneous implantation in rats over 24 weeks showed biocompatibility comparable to PCL with minimal inflammatory response and biphasic degradation behavior characterized by initial swelling followed by controlled volume reduction. In critical‐size femoral defects, PG30 exhibited superior early mechanical properties and increased preosteoblast density at bone interfaces compared to PCL and PCL‐TCP controls at 4 weeks. This developed fabrication methodology enables precise spatial control through 3D printing while preserving gelatin bioactivity. This approach offers a promising advancement for tissue engineering applications requiring enhanced cellular interactions and controlled degradation.